These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21125190)

  • 21. Anti-Ro and Concomitant Anti-La Autoantibodies Strongly Associated With Anti-oxLDL or Anti-Phospholipid Antibody in Systemic Lupus Erythematosus.
    Kurien BT; Fesmire J; Anderson CJ; Scofield RH
    J Clin Rheumatol; 2016 Dec; 22(8):418-425. PubMed ID: 27870764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyslipidemia in systemic lupus erythematosus.
    Szabó MZ; Szodoray P; Kiss E
    Immunol Res; 2017 Apr; 65(2):543-550. PubMed ID: 28168401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.
    Karpouzas GA; Ormseth SR; Ronda N; Hernandez E; Budoff MJ
    J Autoimmun; 2022 May; 129():102815. PubMed ID: 35366608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus.
    Liu A; Rahman M; Hafström I; Ajeganova S; Frostegård J
    Lupus; 2020 Jul; 29(8):825-835. PubMed ID: 32479241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study.
    Chen Q; Reis SE; Kammerer C; Craig W; McNamara DM; Holubkov R; Sharaf BL; Sopko G; Pauly DF; Merz CN; Kamboh MI;
    J Lipid Res; 2011 Apr; 52(4):801-7. PubMed ID: 21252261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negligible synergistic effect of beta2-glycoprotein I on the reactivity of antioxidized low-density lipoprotein antibody to oxidized low-density lipoprotein.
    Matsuda J; Gotoh M; Kawasugi K; Gohchi K; Tsukamoto M; Saitoh N
    Am J Hematol; 1996 Jun; 52(2):114-6. PubMed ID: 8638631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.
    Rodríguez M; Guardiola M; Oliva I; Carles Vallvé J; Ferré R; Masana L; Parra S; Ribalta J; Castro A
    Int J Rheum Dis; 2019 Mar; 22(3):480-487. PubMed ID: 30450745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.
    Orem A; Cimşit G; Değer O; Vanizor B; Karahan SC
    Dermatology; 1999; 198(3):243-6. PubMed ID: 10393445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
    Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
    Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus.
    Borba EF; Carvalho JF; Bonfá E
    Clin Dev Immunol; 2006; 13(2-4):203-8. PubMed ID: 17162363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmunity, oxidized LDL and cardiovascular disease.
    Frostegård J
    Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oxidatively modified lipoproteins and their antibodies in patients with antiphospholipid syndromeand systemic lupus erythematosus].
    Roch B; Kopprasch S; Pietzsch J; Schröder HE
    Z Rheumatol; 2004 Aug; 63(4):331-7. PubMed ID: 15338257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR; Matsuura E; Batuca JR; Ciampa A; Lopez LL; Ferrara F; Iannaccone L; Alves JD
    Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix.
    Auerbach BJ; Bisgaier CL; Wölle J; Saxena U
    J Biol Chem; 1996 Jan; 271(3):1329-35. PubMed ID: 8576120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
    Jansen H; Hop W; van Tol A; Bruschke AV; Birkenhäger JC
    Atherosclerosis; 1994 May; 107(1):45-54. PubMed ID: 7945558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.
    Wu R; Svenungsson E; Gunnarsson I; Haegerstrand-Gillis C; Andersson B; Lundberg I; Elinder LS; Frostegård J
    Clin Exp Immunol; 1999 Mar; 115(3):561-6. PubMed ID: 10193434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
    Li J; Zhang Y; Wang J; Feng P; Chen R; Cao Y; Liu C
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):403-7. PubMed ID: 24754980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is oxidized low-density lipoprotein the connection between atherosclerosis, cardiovascular risk and nephrolithiasis?
    de Freitas ACP; Torres LC; Duarte MDCMB; da Matta MC; Casarini DE; Schor N
    Urolithiasis; 2019 Aug; 47(4):347-356. PubMed ID: 30302491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.